Epineuron Technologies, Inc., a bioelectronic medicine company, announced the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.
Epineuron Technologies Closes Financing for its Breakthrough Nerve Regeneration Device
Previous
Previous
MyndTec Partners with Maness Veteran Medical to Distribute MyndMove™ to US Veterans and Active Military
Next
Next